Netherlands Pharmacovigilance Centre Lareb

Netherlands Pharmacovigilance Centre Lareb

Open Access statistics for Netherlands Pharmacovigilance Centre Lareb, Netherlands, covering academic research published from 2000 to 2024.

Open Access statistics for Netherlands Pharmacovigilance Centre Lareb, Netherlands, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

62%


Total
Publications

536


Total Open
Publications

330


Total
Citations

12K


Open Access
Percentage

62%


Total
Publications

536


Total Open
Publications

330


Total
Citations

12K

Website

download

Breakdown

12% 38% 12% 38%

Publisher Open

12%

Both

38%

Other Platform Open

12%

Closed

38%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

26%OA Journal

OA Journal 26%

69

Hybrid 43%

114

No Guarantees 31%

84

Other Platform Open

Domain 66%

176

Institution 60%

158

Other Internet 6%

17

Preprint 5%

13

Public 3%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
175
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
122
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
91
Europe PMC
Domain
50
Radboud University - Radboud Repository
Institution
27
Erasmus University Rotterdam - EUR Research Repository
Institution
22
University of Oslo - Duo Research Archive
Institution
16
KU Leuven - Lirias
Institution
16
University of Twente - University of Twente Research Information
Institution
15
Université de Lausanne - SERVAL
Institution
13
1 / 5

Data updated 7 April 2025

Share

Share

Share